Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation
Guoxiang Liu, … , Juan C. Troncoso, Huaibin Cai
Guoxiang Liu, … , Juan C. Troncoso, Huaibin Cai
Published May 27, 2014
Citation Information: J Clin Invest. 2014;124(7):3032-3046. https://doi.org/10.1172/JCI72176.
View: Text | PDF
Research Article Neuroscience Article has an altmetric score of 29

Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation

  • Text
  • PDF
Abstract

Subpopulations of dopaminergic (DA) neurons within the substantia nigra pars compacta (SNpc) display a differential vulnerability to loss in Parkinson’s disease (PD); however, it is not clear why these subsets are preferentially selected in PD-associated neurodegeneration. In rodent SNpc, DA neurons can be divided into two subpopulations based on the expression of aldehyde dehydrogenase 1 (ALDH1A1). Here, we have shown that, in α-synuclein transgenic mice, a murine model of PD-related disease, DA neurodegeneration occurs mainly in a dorsomedial ALDH1A1-negative subpopulation that is also prone to cytotoxic aggregation of α-synuclein. Notably, the topographic ALDH1A1 pattern observed in α-synuclein transgenic mice was conserved in human SNpc. Postmortem evaluation of brains of patients with PD revealed a severe reduction of ALDH1A1 expression and neurodegeneration in the ventral ALDH1A1-positive DA subpopulations. ALDH1A1 expression was also suppressed in α-synuclein transgenic mice. Deletion of Aldh1a1 exacerbated α-synuclein–mediated DA neurodegeneration and α-synuclein aggregation, whereas Aldh1a1-null and control DA neurons were comparably susceptible to 1-methyl-4-phenylpyridinium–, glutamate-, or camptothecin-induced cell death. ALDH1A1 overexpression appeared to preferentially protect against α-synuclein–mediated DA neurodegeneration but did not rescue α-synuclein–induced loss of cortical neurons. Together, our findings suggest that ALDH1A1 protects subpopulations of SNpc DA neurons by preventing the accumulation of dopamine aldehyde intermediates and formation of cytotoxic α-synuclein oligomers.

Authors

Guoxiang Liu, Jia Yu, Jinhui Ding, Chengsong Xie, Lixin Sun, Iakov Rudenko, Wang Zheng, Namratha Sastry, Jing Luo, Gay Rudow, Juan C. Troncoso, Huaibin Cai

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Total
Citations: 2 12 5 9 15 10 7 4 9 2 6 5 86
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (86)

Title and authors Publication Year
CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson’s disease models
Leser FS, Júnyor FD, Pagnoncelli IB, Delgado AB, Medeiros I, Nóbrega AC, Andrade BD, de Lima MN, da Silva NE, Jacob L, Boyé K, Geraldo LH, de Souza AM, Maron-Gutierrez T, Castro-Faria-Neto H, Follmer C, Braga C, Neves GA, Eichmann A, Romão LF, Lima FR
Journal of Neuroinflammation 2025
Molecularly distinct striatonigral neuron subtypes differentially regulate locomotion
Dong J, Wang L, Sullivan BT, Sun L, Martinez Smith VM, Chang L, Ding J, Le W, Gerfen CR, Cai H
Nature Communications 2025
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils.
Patterson JR, Kochmanski J, Stoll AC, Kubik M, Kemp CJ, Duffy MF, Thompson K, Howe JW, Cole-Strauss A, Kuhn NC, Miller KM, Nelson S, Onyekpe CU, Beck JS, Counts SE, Bernstein AI, Steece-Collier K, Luk KC, Sortwell CE
npj Parkinson's Disease 2024
The novel peptide LCGM-10 attenuates metabotropic glutamate receptor 5 activity and demonstrates behavioral effects in animal models
Malyshev AV, Pavshintcev VV, Mitkin NA, Sukhanova IA, Gedzun VR, Zlobin AS, Doronin II, Babkin GA, Sawyer TK
Frontiers in behavioral neuroscience 2024
Molecular and cellular mechanisms of selective vulnerability in neurodegenerative diseases.
Kampmann M
Nature reviews. Neuroscience 2024
Sequestosome-1 (SQSTM1/p62) as a target in dopamine catabolite-mediated cellular dyshomeostasis
Masato A, Andolfo A, Favetta G, Bellini EN, Cogo S, Dalla Valle L, Boassa D, Greggio E, Plotegher N, Bubacco L
Cell Death and Disease 2024
Single-cell sequencing of the substantia nigra reveals microglial activation in a model of MPTP
Liu Q, Liu Z, Xie W, Li Y, Wang H, Zhang S, Wang W, Hao J, Geng D, Yang J, Wang L
Frontiers in aging neuroscience 2024
Patch and matrix striatonigral neurons differentially regulate locomotion
Cai H, Dong J, Wang L, Sullivan B, sun L, Chang L, Smith VM, Ding J, Le W, Gerfen C
Research square 2024
Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson’s disease model
del Rey NL, Hernández-Pinedo N, Carrillo M, del Cerro M, Esteban-García N, Trigo-Damas I, Monje MH, Lanciego JL, Cavada C, Obeso JA, Blesa J
NPJ Parkinson's Disease 2024
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons
Basso V, Döbrössy MD, Thompson LH, Kirik D, Fuller HR, Gates MA
Biology 2024
Human midbrain organoids: a powerful tool for advanced Parkinson’s disease modeling and therapy exploration
Cui X, Li X, Zheng H, Su Y, Zhang S, Li M, Hao X, Zhang S, Hu Z, Xia Z, Shi C, Xu Y, Mao C
NPJ Parkinson's Disease 2024
TNF-NFκB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons
Kim TW, Koo SY, Riessland M, Chaudhry F, Kolisnyk B, Cho HS, Russo MV, Saurat N, Mehta S, Garippa R, Betel D, Studer L
Cell 2024
Localization of Melanocortin 1 Receptor in the Substantia Nigra
Ehara A, Ito N, Nakadate K, Tokuda N
International Journal of Molecular Sciences 2024
Sox6 and ALDH1A1 Truncation by Asparagine Endopeptidase Defines Selective Neuronal Vulnerability in Parkinson's Disease
Nie S, Li B, Wang M, Chen Z, Ren J, Li Z, Xu X, Qian Z, Xie Z, Han J, Zhang Z, Zhang Z, Zhu Y, Chen Z, Yang X, Ye K
Advanced Science 2024
Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets
Xia J, Li S, Liu S, Zhang L
2023
Development, wiring and function of dopamine neuron subtypes.
Garritsen O, van Battum EY, Grossouw LM, Pasterkamp RJ
Nature reviews. Neuroscience 2023
Deficiency of Perry syndrome-associated p150(Glued) in midbrain dopaminergic neurons leads to progressive neurodegeneration and endoplasmic reticulum abnormalities.
Yu J, Yang X, Zheng J, Sgobio C, Sun L, Cai H
npj Parkinson's Disease 2023
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson's disease.
Masato A, Plotegher N, Terrin F, Sandre M, Faustini G, Thor A, Adams S, Berti G, Cogo S, De Lazzari F, Fontana CM, Martinez PA, Strong R, Bandopadhyay R, Bisaglia M, Bellucci A, Greggio E, Dalla Valle L, Boassa D, Bubacco L
npj Parkinson's Disease 2023
Unique functional responses differentially map onto genetic subtypes of dopamine neurons.
Azcorra M, Gaertner Z, Davidson C, He Q, Kim H, Nagappan S, Hayes CK, Ramakrishnan C, Fenno L, Kim YS, Deisseroth K, Longnecker R, Awatramani R, Dombeck DA
Nature Neuroscience 2023
Subcellular and regional localization of mRNA translation in midbrain dopamine neurons
B Hobson, L Kong, M Angelo, O Lieberman, E Mosharov, E Herzog, D Sulzer, P Sims
Cell Reports 2022
Preventive Vitamin A Supplementation Improves Striatal Function in 6-Hydroxydopamine Hemiparkinsonian Rats
A Marie, J Leroy, M Darricau, S Alfos, V Smedt-Peyrusse, E Richard, S Vancassel, C Bosch-Bouju
Frontiers in Nutrition 2022
Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase
J Segura-Aguilar, P Muñoz, J Inzunza, M Varshney, I Nalvarte, B Mannervik
Antioxidants 2022
Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity
J Segura-Aguilar, B Mannervik, J Inzunza, M Varshney, I Nalvarte, P Muñoz
NEURAL REGEN RES 2022
An antisense Alu transposon insertion/deletion polymorphism of ALDH1A1 may functionally associate with Parkinson’s disease
H Fan, J Zheng, X Huang, K Wu, L Cui, H Dong, Z Wang, X Zhang, J Zhu
BMC geriatrics 2022
Inhibitory co-transmission from midbrain dopamine neurons relies on presynaptic GABA uptake
R Melani, N Tritsch
Cell Reports 2022
Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
Liu Z, Yang N, Dong J, Tian W, Chang L, Ma J, Guo J, Tan J, Dong A, He K, Zhou J, Cinar R, Wu J, Salinas AG, Sun L, Kumar M, Sullivan BT, Oldham BB, Pitz V, Makarious MB, Ding J, Kung J, Xie C, Hawes SL, Wang L, Wang T, Chan P, Zhang Z, Le W, Chen S, Lovinger DM, Blauwendraat C, Singleton AB, Cui G, Li Y, Cai H, Tang B
Nature Communications 2022
Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons
Sheta R, Teixeira M, Idi W, Pierre M, de Rus Jacquet A, Emond V, Zorca CE, Vanderperre B, Durcan TM, Fon EA, Calon F, Chahine M, Oueslati A
Scientific Reports 2022
Dendritic involvement in inhibition and disinhibition of vulnerable dopaminergic neurons in healthy and pathological conditions.
Evans RC
Neurobiology of Disease 2022
Serotonin transporter-mediated molecular axis regulates regional retinal ganglion cell vulnerability and axon regeneration after nerve injury
R Kingston, D Amin, S Misra, JM Gross, T Kuwajima, MG Anderson
PLoS genetics 2021
Connectivity and Functionality of the Globus Pallidus Externa Under Normal Conditions and Parkinson's Disease
J Dong, S Hawes, J Wu, W Le, H Cai
Frontiers in neural circuits 2021
ALDH1A1 Genetic Variations May Modulate Risk of Parkinson’s Disease in Han Chinese Population
HH Fan, Q Guo, J Zheng, YZ Lian, SS Huang, Y Sun, M Zou, JH Zhu, X Zhang
Frontiers in neuroscience 2021
Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson’s Disease
K Carmichael, RC Evans, E Lopez, L Sun, M Kumar, J Ding, ZM Khaliq, H Cai
Frontiers in neural circuits 2021
Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
SM Graves, SE Schwarzschild, RA Tai, Y Chen, DJ Surmeier
Neurobiology of Disease 2021
Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson’s Disease
A Marie, M Darricau, K Touyarot, LC Parr-Brownlie, C Bosch-Bouju
Journal of Parkinson's disease 2021
Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
AP Chen, L Chen, TA Kim, Q Xiong
Biomedicines 2021
ASL expression in ALDH1A1+ neurons in the substantia nigra metabolically contributes to neurodegenerative phenotype
S Lerner, R Eilam, L Adler, J Baruteau, T Kreiser, M Tsoory, A Brandis, T Mehlman, M Ryten, JA Botia, SG Ruiz, AC Garcia, C Dionisi-Vici, G Ranucci, M Spada, R Mazkereth, R McCarter, R Izem, TJ Balmat, R Richesson, MR Baumgartner, JK Bedoyan, G Berry, SA Berry, P Burgard, L Burrage, C Coughlin, GA Diaz, G Enns, RC Gallagher, A Gropman, CO Harding, G Hoffmann, CL Mons, SE McCandless, JL Merritt, SC Nagamani, A Schulze, J Seminara, T Stricker, M Tuchman, S Waisbren, JD Weisfeld-Adams, D Wong, M Yudkoff, E Gazit, SC Nagamani, A Erez
Human Genetics 2021
Synaptic dysfunction of Aldh1a1 neurons in the ventral tegmental area causes impulsive behaviors
X Li, W Chen, X Huang, W Jing, T Zhang, Q Yu, H Yu, H Li, Q Tian, Y Ding, Y Lu
Molecular Neurodegeneration 2021
The essential role of transcription factor Pitx3 in preventing mesodiencephalic dopaminergic neurodegeneration and maintaining neuronal subtype identities during aging
Y Wang, , Y Wang, S Li, H Cai, W Le
Cell Death and Disease 2021
Diverse midbrain dopaminergic neuron subtypes and implications for complex clinical symptoms of Parkinson’s disease
K Carmichael, B Sullivan, E Lopez, L Sun, H Cai
2021
Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins
MP Luppi, M Azcorra, G Caronia-Brown, JF Poulin, Z Gaertner, S Gatica, OA Moreno-Ramos, N Nouri, M Dubois, YC Ma, C Ramakrishnan, L Fenno, YS Kim, K Deisseroth, F Cicchetti, DA Dombeck, R Awatramani
Cell Reports 2021
Inhibition of β-catenin dependent WNT signalling upregulates the transcriptional repressor NR0B1 and downregulates markers of an A9 phenotype in human embryonic stem cell-derived dopaminergic neurons: Implications for Parkinson’s disease
JM Haynes, SM Sibuea, AA Aguiar, F Li, JK Ho, CW Pouton, R Zhou
PloS one 2021
Impact of α‐synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology
F Sun, A Salinas, S Filser, S Blumenstock, J MedinaLuque, J Herms, C Sgobio
Brain Pathology 2021
Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease
A Masato, M Sandre, A Antonini, L Bubacco
Current neuropharmacology 2021
Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson’s disease through mitochondrial dysfunction
CY Kao, M Xu, L Wang, SC Lin, HJ Lee, L Duraine, HJ Bellen, DS Goldstein, SY Tsai, MJ Tsai, EA Fon
PLoS genetics 2020
The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
G Minakaki, D Krainc, LF Burbulla
Frontiers in Cell and Developmental Biology 2020
Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease
B Galet, H Cheval, P Ravassard
Frontiers in neurology 2020
Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice
N Ninkina, TV Tarasova, KD Chaprov, AY Roman, MS Kukharsky, LG Kolik, R Ovchinnikov, AA Ustyugov, AD Durnev, VL Buchman
Neurobiology of Aging 2020
Heterogeneity of dopamine release sites in health and degeneration
JJ Lebowitz, H Khoshbouei
Neurobiology of Disease 2020
Classification of Midbrain Dopamine Neurons Using Single-Cell Gene Expression Profiling Approaches
JF Poulin, Z Gaertner, OA Moreno-Ramos, R Awatramani
Trends in Neurosciences 2020
Toward Generating Subtype-Specific Mesencephalic Dopaminergic Neurons in vitro
T Cardoso, M Lévesque
Frontiers in Cell and Developmental Biology 2020
Meta-analysis of honey bee neurogenomic response links Deformed wing virus type A to precocious behavioral maturation
IM Traniello, SA Bukhari, J Kevill, AC Ahmed, AR Hamilton, NL Naeger, DC Schroeder, GE Robinson
Scientific Reports 2020
The “Sick-but-not-Dead” Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases
DS Goldstein
Seminars in Neurology 2020
Alpha-Synuclein in Alcohol Use Disorder, Connections with Parkinson’s Disease and Potential Therapeutic Role of 5’ Untranslated Region-Directed Small Molecules
CM Cahill, R Aleyadeh, J Gao, C Wang, JT Rogers
Biomolecules 2020
Age-dependent Nigral Dopaminergic Neurodegeneration and α-Synuclein Accumulation in RGS6-Deficient Mice
Zili Luo, Katelin E. Ahlers-Dannen, Mackenzie M. Spicer, Jianqi Yang, Stephanie L Alberico, Hanna E Stevens, Nandakumar S. Narayanan, Rory A. Fisher
JCI Insight 2019
ALDH1A1 regulates postsynaptic μ–opioid receptor expression in dorsal striatal projection neurons and mitigates dyskinesia through transsynaptic retinoic acid signaling
J Pan, J Yu, L Sun, C Xie, L Chang, J Wu, S Hawes, S SaezAtienzar, W Zheng, J Kung, J Ding, W Le, S Chen, H Cai
Scientific Reports 2019
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
A Masato, N Plotegher, D Boassa, L Bubacco
Molecular Neurodegeneration 2019
Sex-Specific Proteomic Changes Induced by Genetic Deletion of Fibroblast Growth Factor 14 (FGF14), a Regulator of Neuronal Ion Channels
ML Sowers, JD Re, PA Wadsworth, AS Shavkunov, C Lichti, K Zhang, F Laezza
Proteomes 2019
Unbalanced calcium channel activity underlies selective vulnerability of nigrostriatal dopaminergic terminals in Parkinsonian mice
C Sgobio, L Sun, J Ding, J Herms, DM Lovinger, H Cai
Scientific Reports 2019
Distinct Connectivity and Functionality of Aldehyde Dehydrogenase 1a1-Positive Nigrostriatal Dopaminergic Neurons in Motor Learning
J Wu, J Kung, J Dong, L Chang, C Xie, A Habib, S Hawes, N Yang, V Chen, Z Liu, R Evans, B Liang, L Sun, J Ding, J Yu, S Saez-Atienzar, B Tang, Z Khaliq, DT Lin, W Le, H Cai
Cell Reports 2019
Induced pluripotent stem cell‐based modeling of mutant LRRK 2‐associated Parkinson's disease
B Weykopf, S Haupt, J Jungverdorben, LJ Flitsch, M Hebisch, GH Liu, K Suzuki, JC Belmonte, M Peitz, S Blaess, A Till, O Brüstle
The European journal of neuroscience 2019
Isoindole Linkages Provide a Pathway for DOPAL-Mediated Cross-Linking of α-Synuclein
JW Werner-Allen, S Monti, JF DuMond, RL Levine, A Bax
Biochemistry 2018
Alcohol consumption and risk for Parkinson’s disease: a systematic review and meta-analysis
FJ Jiménez-Jiménez, H Alonso-Navarro, E García-Martín, JA Agúndez
Journal of Neurology 2018
Multifaceted Regulation of ALDH1A1 by Cdk5 in Alzheimer’s Disease Pathogenesis
K Nikhil, K Viccaro, K Shah
Molecular Neurobiology 2018
Combinatorial Expression of Grp and Neurod6 Defines Dopamine Neuron Populations with Distinct Projection Patterns and Disease Vulnerability
DJ Kramer, D Risso, P Kosillo, J Ngai, HS Bateup
eNeuro 2018
Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism
A Anandhan, MS Jacome, S Lei, P Hernandez-Franco, A Pappa, MI Panayiotidis, R Powers, R Franco
Brain Research Bulletin 2017
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
N Plotegher, G Berti, E Ferrari, I Tessari, M Zanetti, L Lunelli, E Greggio, M Bisaglia, M Veronesi, S Girotto, MD Serra, C Perego, L Casella, L Bubacco
Scientific Reports 2017
Identification of temporal genes involved in the mechanisms of spinal cord injury
S Ma, J Wang, L Liu, L Xia, R Tao
Spinal Cord 2017
Aldehyde dehydrogenase 1–positive nigrostriatal dopaminergic fibers exhibit distinct projection pattern and dopamine release dynamics at mouse dorsal striatum
C Sgobio, J Wu, W Zheng, X Chen, J Pan, AG Salinas, MI Davis, DM Lovinger, H Cai
Scientific Reports 2017
Molecular Programming of Mesodiencephalic Dopaminergic Neuronal Subsets
MP Smidt
Frontiers in neuroanatomy 2017
Pitx3 and En1 determine the size and molecular programming of the dopaminergic neuronal pool
WM Kouwenhoven, L Oerthel, MP Smidt, R Zhou
PloS one 2017
Dopamine Inhibition Differentially Controls Excitability of Substantia Nigra Dopamine Neuron Subpopulations through T-Type Calcium Channels
RC Evans, M Zhu, ZM Khaliq
The Journal of neuroscience : the official journal of the Society for Neuroscience 2017
Proteomic profiling of neuronal mitochondria reveals modulators of synaptic architecture
LC Graham, SL Eaton, PJ Brunton, A Atrih, C Smith, DJ Lamont, TH Gillingwater, G Pennetta, P Skehel, TM Wishart
Molecular Neurodegeneration 2017
Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson’s Disease Substantia Nigra
E Grünblatt, J Ruder, CM Monoranu, P Riederer, MB Youdim, SA Mandel
Neurotoxicity Research 2017
Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease
DM Weisenhorn, F Giesert, W Wurst
Journal of Neurochemistry 2016
Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress
M Akbar, MM Essa, G Daradkeh, MA Abdelmegeed, Y Choi, L Mahmood, BJ Song
Brain Research 2016
Blood transcriptomics of drug-naïve sporadic Parkinson’s disease patients
R Calligaris, M Banica, P Roncaglia, E Robotti, S Finaurini, C Vlachouli, L Antonutti, F Iorio, A Carissimo, T Cattaruzza, A Ceiner, D Lazarevic, A Cucca, N Pangher, E Marengo, D Bernardo, G Pizzolato, S Gustincich
BMC Genomics 2015
Neurotoxin-Induced DNA Damage is Persistent in SH-SY5Y Cells and LC Neurons
Y Wang, PR Musich, K Cui, Y Zou, MY Zhu
Neurotoxicity Research 2015
Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression
G Liu, C Sgobio, X Gu, L Sun, X Lin, J Yu, L Parisiadou, C Xie, N Sastry, J Ding, KM Lohr, GW Miller, Y Mateo, DM Lovinger, H Cai
Human Molecular Genetics 2015
Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons
JI Kim, S Ganesan, SX Luo, YW Wu, E Park, EJ Huang, L Chen, JB Ding
Science 2015
Molecular Heterogeneity of Midbrain Dopaminergic Neurons – Moving Toward Single Cell Resolution
A Anderegg, JF Poulin, R Awatramani
FEBS Letters 2015
Cell type-specific gene expression profiling in brain tissue: comparison between TRAP, LCM and RNA-seq
Kim T, Lim CS, Kaang BK
BMB Reports 2015
Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance
A Domanskyi, H Alter, MA Vogt, P Gass, IA Vinnikov
Frontiers in cellular neuroscience 2014
Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
L Brichta, P Greengard
Frontiers in neuroanatomy 2014
Inflammation rapidly modulates the expression of ALDH1A1 (RALDH1) and vimentin in the liver and hepatic macrophages of rats in vivo
K Ito, R Zolfaghari, L Hao, A Ross
Nutrition & Metabolism 2014
Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease
H Cai, G Liu, L Sun, J Ding
Translational Neurodegeneration 2014
Rgs6 is Required for Adult Maintenance of Dopaminergic Neurons in the Ventral Substantia Nigra
P Bifsha, J Yang, RA Fisher, J Drouin, GP Copenhaver
PLoS genetics 2014

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Blogged by 3
Posted by 2 X users
124 readers on Mendeley
See more details